Advisor Group Holdings, Inc. Amgen Inc Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 194,519 shares of AMGN stock, worth $57.3 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

194,519

Previous 152,179 27.82%

Holding current value

$57.3 Million

Previous $47.5 Million 31.81%

% of portfolio

0.15%

Previous 0.12%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $13.1 Million - $14.3 Million	42,340 Added 27.82%	194,519 $62.7 Million
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $14.1 Million - $17.1 Million	-53,648 Reduced 26.06%	152,179 $47.5 Million
Q1 2024 May 10, 2024	SELL	$268.87 - $324.56 $29.8 Million - $36 Million	-110,933 Reduced 35.02%	205,827 $58.5 Million
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $20.3 Million - $22.9 Million	-79,420 Reduced 20.05%	316,760 $91.2 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $25.3 Million - $31.4 Million	115,603 Added 41.2%	396,180 $106 Million
Q2 2023 Aug 21, 2023	SELL	$214.27 - $253.37 $89.7 Million - $106 Million	-418,612 Reduced 59.87%	280,577 $62.3 Million
Q2 2023 Aug 10, 2023	BUY	$214.27 - $253.37 $92.3 Million - $109 Million	430,851 Added 160.56%	699,189 $155 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $629,954 - $767,808	-2,790 Reduced 1.03%	268,338 $64.9 Million
Q4 2022 Feb 10, 2023	BUY	$229.03 - $291.01 $4.14 Million - $5.26 Million	18,076 Added 7.14%	271,128 $71.2 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $2.47 Million - $2.78 Million	11,001 Added 4.54%	253,052 $57.1 Million
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $2.98 Million - $3.31 Million	12,909 Added 5.63%	242,051 $59 Million
Q1 2022 May 04, 2022	BUY	$219.27 - $242.57 $10.8 Million - $11.9 Million	49,204 Added 27.34%	229,142 $52.2 Million
Q3 2021 Nov 05, 2021	SELL	$212.27 - $248.7 $964,342 - $1.13 Million	-4,543 Reduced 2.46%	179,938 $38.3 Million
Q2 2021 Aug 02, 2021	SELL	$233.58 - $259.14 $573,438 - $636,188	-2,455 Reduced 1.31%	184,481 $45.1 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $1.19 Million - $1.39 Million	-5,376 Reduced 2.8%	186,936 $46.6 Million
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $2.81 Million - $3.35 Million	-13,002 Reduced 6.33%	192,312 $44.3 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $1.99 Million - $2.21 Million	8,470 Added 4.3%	205,314 $51.9 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $154 Million - $189 Million	-777,437 Reduced 79.8%	196,844 $46.5 Million
Q1 2020 May 18, 2020	BUY	$182.24 - $241.7 $178 Million - $235 Million	974,281 New	974,281 $38.9 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Amgen Inc Transaction History